PTCH1 and cyst: In the 2022 classification, OKC remains classified as a cyst; molecular studies have detected frequent mutations in the tumor suppressor gene PTCH1, a gene that activates the SHH pathway, leading to aberrant epithelial proliferation [1], sparking debates on whether OKC is a cyst or a cystic neoplasm.